Reactivation and role of HHV-8 in Kaposi's sarcoma initiation (Q34295807)

1 August 2017

1 reference

title

Reactivation and role of HHV-8 in Kaposi's sarcoma initiation (English)

1 reference

1 August 2017

1 reference

Ensoli B

1

1 reference

PubMed ID

11430595

1 August 2017

Stürzl M

series ordinal

2

1 reference

PubMed ID

11430595

1 August 2017

Monini P

series ordinal

3

1 reference

1 August 2017

1 January 2001

1 reference

Advances in Cancer Research

1 August 2017

1 reference

1 August 2017

81

1 reference

1 August 2017

161-200

1 reference

Kaposi's sarcoma in renal transplant recipients. Ultrastructural and immunoperoxidase study of four cases

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Microsatellite instability in primary neoplasms from HIV + patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

A histologic and flow cytometric study of Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Infectious human herpesvirus 8 in a healthy North American blood donor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human herpesvirus 8 detection in nasal secretions and saliva

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Induction of human herpesvirus-8 gene expression by recombinant interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Localization of human herpesvirus type 8 (HHV-8) in the Kaposi's sarcoma tissues and the semen specimens of HIV-1 infected and uninfected individuals by utilizing in situ polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

HHV8 cell-associated viraemia and clinical presentation of Mediterranean Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma: a reversible hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Interferon-gamma marks activated T lymphocytes in AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The immunoexpression of bcl-2 and p53 in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Molecular analysis of clonality in Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Increased cytokine production in mononuclear cells of healthy elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements in the bFGF promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

1 reference

7 January 2021

In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human herpesvirus 8 and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

p53 inhibition by the LANA protein of KSHV protects against cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Disseminated Kaposi's sarcoma syndrome in young homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma in HIV-negative homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma in Italy before and after the AIDS epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Birthplace and classic Kaposi's sarcoma in Italy. Associazione Italiana Registri Tumori

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma: an extensively disseminated form in young homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Repetitive strain injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma after immunosuppressive therapy with prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Association of Kaposi's sarcoma associated herpesvirus (KSHV) DNA in bronchoalveolar lavage fluid of HIV infected individuals with bronchoscopically diagnosed tracheobronchial Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Expression of int-2 oncogene in Kaposi's sarcoma lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Monoclonality or Oligoclonality of Human Herpesvirus 8 Terminal Repeat Sequences in Kaposi's Sarcoma and Other Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Purified Tat induces inflammatory response genes in Kaposiʼs sarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Interleukin 12: newest member of the antiangiogenesis club

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma: further immunohistologic evidence of a vascular endothelial origin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

A novel endothelial-specific membrane protein is a marker of cell-cell contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma and new herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human Mig chemokine: biochemical and functional characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Dominant human herpesvirus type 8 RNA transcripts in classical and AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Endothelial cell markers in vascular neoplasms: an immunohistochemical study comparing factor VIII-related antigen, blood group specific antigens, 6-keto-PGF1 alpha, and Ulex europaeus 1 lectin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Shedding of cytomegalovirus and herpesviruses 6, 7, and 8 in saliva of human immunodeficiency virus type 1-infected patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

HHV-8 and multiple myeloma in the UK

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Over-expression of hepatocyte growth factor in human Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Cytokine regulation of endothelial cell function: from molecular level to the bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

HHV-8 and multiple myeloma in France

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Sexual transmission and the natural history of human herpesvirus 8 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Immunological Studies in Kaposi's Sarcoma in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma with benign course in a homosexual

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Detection and subtyping of human herpesvirus-8 in renal transplant patients before and after remission of Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Latent BK virus infection and Kaposi's sarcoma pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

p53 protein overexpression is a common but late event in the pathogenesis of iatrogenic and AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Epidermal tumour necrosis factor alpha and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. An immunohistological study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Bcl-2 and p53 immunoprofile in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Cytokines and endothelial cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Monoclonal Origin of Multicentric Kaposi's Sarcoma Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Immune activation in HIV-infected African individuals. Italian-Ugandan AIDS cooperation program

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Cultured, AIDS-related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma: a review and recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Ultrastructural characterization of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in Kaposi's sarcoma lesions: electron microscopy permits distinction from cytomegalovirus (CMV).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Mechanism of paclitaxel activity in Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human herpesvirus 8 DNA sequences in CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma in mainland Tanzania: a report of 117 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human herpesvirus 8 cellular immune responses in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Cell adhesion and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma in Uganda: A clinico‐pathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's Sarcoma in Uganda: Geographic and Ethnic Distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The role of immunosuppression and immune-activation in classic Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The appearance of Kaposi sarcoma during corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Cultured Kaposi's sarcoma-derived cells express functional PDGF A-type and B-type receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Interleukin 1beta induces expression of human herpesvirus 8 encoded genes in BCBL-1 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Inflammatory mediators stimulate granulocyte adherence to cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma after kidney transplantation. Report of complete remission of cutaneous and visceral involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Clinical aspects of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Identification of human herpesvirus 8-specific cytotoxic T-cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma in organ transplant recipients: report of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2981005-8

7 January 2021

10.1016/S0065-230X(01)81005-8

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11430595